A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases.
| Website | http://proxygen.com |
| Revenue | $5.1 million |
| Employees | 33 (24 on RocketReach) |
| Phone | +43 1 2261030 |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Drug Development, Pharmaceutical Research, Biomedical Research, Biotechnology, Protein Degradation, Scientific Research, Pharmaceutical Science, Therapeutic Innovation, Biopharma, Therapeutic Development, Exploratory Research, Molecular Biology, New Treatments, Life Sciences, Clinical Development, Patient Care, Healthcare Innovation |
| Competitors | Auth0 by Okta, Okta, Amazon, Google, OneLogin by One Identity, Ping Identity, Duo Security, Microsoft, IBM +30 more (view full list) |
Looking for a particular Proxygen employee's phone or email?
Proxygen Questions
The Proxygen annual revenue was $5.1 million in 2026.
Bernd Boidol is the CEO of Proxygen.
24 people are employed at Proxygen.
Top Proxygen Employees
-
Bernd Boidol
CEO at Proxygen
Vienna, AT1 -
Vanessa Nancy-Portebois
Vice-President Drug Discovery at Proxygen
Île-de-France, France1 -
Chiara Conti
Chief Scientific Officer at Proxygen
Basel, BS, CH22 -
4
-
Craig Avery
Head of Chemistry at Proxygen
Nottingham, GB1 -
2
-
Kai-Chun Li
Group Leader at Proxygen
Vienna, AT1 -
1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
